Phase II Study of the Adjunctive Use of Azacitidine in Patients Undergoing Reduced Intensity Allogeneic Transplantation Acute Myeloid Leukaemia and Myelodysplasia. (RICAZA)

Project Details

Short titlePhase II Study of the Adjunctive Use of Azacitidine in Patients Undergoing Reduced Intensity Allogeneic Transplantation Acute Myeloid Leukaemia and Myelodysplasia. (RICAZA)
StatusFinished
Effective start/end date1/12/0831/12/17

Funding

  • CELGENE INTERNATIONAL SARL